| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PNAS..109.3012C |
| P356 | DOI | 10.1073/PNAS.1117359109 |
| P932 | PMC publication ID | 3286988 |
| P698 | PubMed publication ID | 22315415 |
| P5875 | ResearchGate publication ID | 221815570 |
| P50 | author | Boris Reizis | Q40150235 |
| Volker Thiel | Q56871923 | ||
| Burkhard Ludewig | Q87843505 | ||
| P2093 | author name string | Walter Reith | |
| Sonja Firner | |||
| Stephanie Hugues | |||
| Luisa Cervantes-Barragan | |||
| Kanako L Lewis | |||
| P2860 | cites work | Functional role of type I and type II interferons in antiviral defense | Q24276429 |
| Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development | Q24645273 | ||
| Estimating the precursor frequency of naive antigen-specific CD8 T cells | Q24674109 | ||
| Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells | Q27487038 | ||
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| Type I interferon: friend or foe? | Q28293186 | ||
| Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection | Q28511064 | ||
| Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual | Q30422031 | ||
| Anatomy of viral persistence | Q33489565 | ||
| Plasmacytoid dendritic cells in HIV infection: striking a delicate balance | Q33805319 | ||
| Innate sensing of HIV-infected cells | Q33838296 | ||
| Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. | Q33841892 | ||
| Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections | Q33874809 | ||
| Features of responding T cells in cancer and chronic infection. | Q33941340 | ||
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | Q34096499 | ||
| Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. | Q34411316 | ||
| Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. | Q34583009 | ||
| Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. | Q34891171 | ||
| Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest | Q35140212 | ||
| Helping the CD8(+) T-cell response | Q35852274 | ||
| Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. | Q36229473 | ||
| Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus | Q36238039 | ||
| T cells and viral persistence: lessons from diverse infections | Q36238129 | ||
| Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo | Q36369895 | ||
| Tracking epitope-specific T cells. | Q36454999 | ||
| Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. | Q36623371 | ||
| Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. | Q37222231 | ||
| Antigen-presentation properties of plasmacytoid dendritic cells | Q37272231 | ||
| Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer | Q37787437 | ||
| Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells | Q39606948 | ||
| Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection | Q39898411 | ||
| Plasmacytoid dendritic cells are dispensable during primary influenza virus infection | Q39898455 | ||
| The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection | Q40099207 | ||
| Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells | Q41477085 | ||
| Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. | Q41913810 | ||
| Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen | Q43554100 | ||
| Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells | Q45151385 | ||
| Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. | Q45159348 | ||
| Type I IFN substitutes for T cell help during viral infections | Q45309998 | ||
| Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice | Q45384372 | ||
| CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion | Q45418190 | ||
| Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection | Q45757704 | ||
| MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice | Q45778639 | ||
| Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. | Q52012326 | ||
| Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon | Q57017389 | ||
| Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ | Q79370164 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 3012-3017 | |
| P577 | publication date | 2012-02-06 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Plasmacytoid dendritic cells control T-cell response to chronic viral infection | |
| P478 | volume | 109 |
| Q38068788 | A global "imaging'' view on systems approaches in immunology. |
| Q92667638 | A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection |
| Q36736634 | Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon |
| Q35483850 | Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms |
| Q42245307 | Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? |
| Q36822696 | Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation |
| Q41779828 | Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors |
| Q35866588 | Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor. |
| Q34749950 | Beta2-adrenoceptor stimulation suppresses TLR9-dependent IFNA1 secretion in human peripheral blood mononuclear cells |
| Q64260954 | Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity |
| Q36553658 | CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells |
| Q37500448 | CD4+ T-cell help is required for effective CD8+ T cell-mediated resolution of acute viral hepatitis in mice |
| Q38964925 | CD8+ T Cells Orchestrate pDC-XCR1+ Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming |
| Q38456783 | CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation |
| Q38949057 | Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells |
| Q36033541 | Classical dendritic cells as a unique immune cell lineage. |
| Q64250220 | Complexities of Type I Interferon Biology: Lessons from LCMV |
| Q35111019 | Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection |
| Q33927128 | Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming |
| Q26799991 | Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets |
| Q40567280 | Dendritic Cells Are Dispensable for T Cell Priming and Control of Acute Lymphocytic Choriomeningitis Virus Infection. |
| Q27010312 | Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle? |
| Q27001626 | Dendritic cells: arbiters of immunity and immunological tolerance |
| Q49644698 | Diverse functions of protein tyrosine phosphatase σ in the nervous and immune systems. |
| Q47550781 | Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference |
| Q40239444 | Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs |
| Q35740053 | Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation |
| Q40106843 | Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection |
| Q39868598 | FcγRIIB prevents inflammatory type I IFN production from plasmacytoid dendritic cells during a viral memory response. |
| Q42223044 | Frequencies of dendritic cells and Toll-like receptor 3 in neonates born to HBsAg-positive mothers with different HBV serological profiles |
| Q37416120 | Fueling autoimmunity: type I interferon in autoimmune diseases. |
| Q35078558 | Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life |
| Q34230520 | Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus |
| Q99248728 | Genetic models of human and mouse dendritic cell development and function |
| Q40158053 | Human Plasmacytoid Dendritic Cells Elicited Different Responses after Infection with Pathogenic and Nonpathogenic Junin Virus Strains. |
| Q38101992 | Human dendritic cell subsets |
| Q35242599 | Human pDCs preferentially sense enveloped hepatitis A virions |
| Q38691525 | Hybrid approach to model the spatial regulation of T cell responses |
| Q36926351 | Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness |
| Q28079717 | Innate and Adaptive Immune Regulation During Chronic Viral Infections |
| Q34055968 | Innate immune regulation by STAT-mediated transcriptional mechanisms. |
| Q91877875 | Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population |
| Q35149329 | Interferon-α production by plasmacytoid dendritic cells is dispensable for an effective anti-cytomegalovirus response in adaptor protein-3-deficient mice |
| Q98161951 | Interplay between SARS-CoV-2 and the type I interferon response |
| Q36967801 | Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. |
| Q90314834 | Leukemia Inhibitory Factor Inhibits Plasmacytoid Dendritic Cell Function and Development |
| Q57018427 | Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition |
| Q35597306 | MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity |
| Q38408658 | Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity |
| Q55031214 | Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells. |
| Q27319958 | Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus |
| Q34845501 | Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion. |
| Q37020616 | Networking at the level of host immunity: immune cell interactions during persistent viral infections |
| Q28509751 | Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens |
| Q99731999 | Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰ |
| Q38200784 | Perspectives on antigen presenting cells in zebrafish |
| Q33956662 | Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis |
| Q58556211 | Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease |
| Q36041511 | Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection |
| Q35034249 | Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections |
| Q37019332 | Plasmacytoid dendritic cells in HIV infection |
| Q36796084 | Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation |
| Q35215887 | Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice |
| Q38239650 | Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation |
| Q28771472 | Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells |
| Q36818027 | Re(de)fining the dendritic cell lineage. |
| Q30252210 | Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions |
| Q29542292 | Role of plasmacytoid dendritic cell subsets in allergic asthma |
| Q38825270 | Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells |
| Q94588769 | Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
| Q27342449 | Slc15a4, a gene required for pDC sensing of TLR ligands, is required to control persistent viral infection |
| Q64118767 | Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat |
| Q38057999 | TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease |
| Q64093135 | The Role of Myeloid-Derived Cells in the Progression of Liver Disease |
| Q36731249 | The multifaceted biology of plasmacytoid dendritic cells |
| Q30047565 | The role of dendritic cells in autoimmunity |
| Q36611354 | Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection |
| Q36660641 | Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity |
| Q37246472 | Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells |
| Q37534064 | Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate. |
| Q37468541 | Transcriptional Control of Dendritic Cell Development. |
| Q35035310 | Transcriptional reprogramming of CD11b+Esam(hi) dendritic cell identity and function by loss of Runx3. |
Search more.